Article information
Article
These are the options to access the full texts of the publication Reumatología Clínica (English Edition)
References
[1]
I.E. Lundberg, A. Tjärnlund, M. Bottai, et al.
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.
Ann Rheum Dis, 76 (2017), pp. 1955-1964
[2]
J.S.S. Concha, M. Tarazi, C.J. Kushner, R.G. Gaffney, V.P. Werth.
The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria.
Br J Dermatol, 180 (2019), pp. 1001-1008
[3]
K. Tang, H. Zhang, H. Jin.
Clinical characteristics and management of patients with clinical amyopathic dermatomyositis: a retrospective study of 64 patients at a tertiary dermatology department.
Front Med, 8 (2021), pp. 783416
[4]
L. Liang, Y.M. Zhang, H. Chen, et al.
Anti-Mi-2 antibodies characterize a distinct clinical subset of dermatomyositis with favourable prognosis.
Eur J Dermatol, 30 (2020), pp. 151-158
[5]
H. Ali, A. On, E. Xing, C. Shen, V.P. Werth.
Dermatomyositis: focus on cutaneous features, etiopathogenetic mechanisms and their implications for treatment.
Semin Immunopathol, 47 (2025), pp. 32
[6]
R. Waldman, M.E. DeWane, J. Lu.
Dermatomyositis: diagnosis and treatment.
J Am Acad Dermatol, 82 (2020), pp. 283-296
